DeepCurrents Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

DeepCurrents Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.3M	Buy	79,900 +8,264	+12%	+$1.81M	0.58%	58
2026 Q1	$13.5M	Buy	71,636 +1,150	+2%	+$201K	0.43%	75
2025 Q4	$12M	Buy	70,486 +136	+0.2%	+$20.9K	0.39%	82
2025 Q3	$9.27M	Buy	70,350 +3,747	+6%	+$449K	0.24%	93
2025 Q2	$7.07M	Buy	66,603 +14,550	+28%	+$1.58M	0.24%	89
2025 Q1	$6.46M	Buy	+52,053	New	+$6.79M	0.2%	109
2022 Q3	–	Sell	-43,249	Closed	-$6.75M	–	240
2022 Q2	$6.75M	Sell	43,249 -125,954	-74%	-$19.4M	0.27%	84
2022 Q1	$26.3M	Buy	169,203 +28,021	+20%	+$4.07M	0.82%	37
2021 Q4	$18M	Buy	141,182 +42,446	+43%	+$5.58M	0.56%	52
2021 Q3	$12.9M	Buy	+98,736	New	+$14.9M	0.38%	65
2019 Q2	–	Sell	-28,069	Closed	-$4.01M	–	95
2019 Q1	$4.01M	Buy	28,069 +22,888	+442%	+$2.99M	0.35%	54
2018 Q4	$643K	Buy	+5,181	New	+$769K	0.08%	85

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

DeepCurrents Investment Group's JAZZ Position: Q2 2026 in Review

DeepCurrents Investment Group increased its Jazz Pharmaceuticals (JAZZ) stake by 12% in Q2 2026, buying an estimated $1.81M and bringing the position to 79,900 shares worth $19.3M. The position accounts for 0.58% of the portfolio, ranked #58.

DeepCurrents Investment Group first reported a position in JAZZ in Q4 2018 and has held it in 12 quarters since. The position peaked at $26.3M in Q1 2022. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

DeepCurrents Investment Group held 79,900 shares of Jazz Pharmaceuticals worth $19.3M as of Q2 2026.
DeepCurrents Investment Group bought 8,264 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.81M.
Jazz Pharmaceuticals made up 0.58% of DeepCurrents Investment Group's portfolio in Q2 2026, its #58 holding.
DeepCurrents Investment Group first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 12 quarters since.
DeepCurrents Investment Group's Jazz Pharmaceuticals position peaked at $26.3M in Q1 2022.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on DeepCurrents Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.